Cannabis and aging: research remains in its infancy.
Cannabis and aging: research remains in its infancy.
复制标题
大麻与衰老：研究仍处于起步阶段。
DOI：
10.1080/00952990.2021.1949334
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Gruber,StaciA
中科院分区：
文献类型：
--
作者：
Zolotov,Yuval;Gruber,StaciA
人口老龄化是我们整个社会，特别是医疗保健系统和提供者的迫切关切。大麻和大麻素可能会缓解老年人普遍存在的一系列疾病，包括疼痛、关节炎、失眠、焦虑等。然而，迄今为止，支持医用大麻和大麻素对这一人群的安全性和有效性的证据仍然是初步的(1)。尽管如此，用于医疗目的的大麻在全世界各年龄段继续发展，尤其是在老年人中(2)。
Aging of the population is a pressing concern for our society in general, and for healthcare systems and providers in particular. Cannabis and cannabinoids may potentially alleviate a wide array of medical conditions that are prevalent among older adults, including pain, arthritis, insomnia, anxiety, and others. To date, however, the evidence supporting the safety and efficacy of medical cannabis and cannabinoids for this population remains preliminary (1). Notwithstanding, the use of cannabis for medical purposes continues to evolve worldwide across all age groups, and specifically so among older adults (2).